483
Septodont Inc.Septodont Inc. – FDA 483, Aug 12, 2019
Record Details
An FDA inspection of Sagent-dont Inc., a drug manufacturer in Louisville, CO, revealed significant deficiencies in their quality system. Observations included inadequate deviation investigations, poor laboratory control mechanisms, and failures to follow written production and process control procedures. One critical observation regarding deviation investigations was a repeat from a previous inspection.
View Company Profile
ID · 86fbf988-8995-4c8e-8645-8a3874509447
Other documents for Septodont Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.